Adding the ‘medicines’ back into personalized medicine to improve cancer treatment outcomes

E-ISSN： 1365-2125|80|5|929-931

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.5, 2015-11, pp. : 929-931

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Personalized medicine for breast cancer: moving forward and going back

By Ross Jeffrey S Symmans W Fraser Pusztai Lajos Hortobagyi Gabriel N

Personalized Medicine, Vol. 3, Iss. 4, 2006-11 ,pp. : 363-370

Future Medicine

Access to resources Recommend Favorite

Personalized Cancer Medicine

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 2-2

Karger

Access to resources Recommend Favorite

Personalized Treatment of Colorectal Cancer

Oncology Research and Treatment, Vol. 35, Iss. 1, 2012-01 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized cancer treatment

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 201-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of metastatic kidney cancer in the era of personalized medicine

By Monzon Jose G. Heng Daniel Y. C.

Critical Reviews in Clinical Laboratory Sciences, Vol. 51, Iss. 2, 2014-04 ,pp. : 85-97

Informa Healthcare

Access to resources Recommend Favorite